https://caltcm.memberclicks.net/assets/documents/acc_aha_chf_2013_guidelines.pdf

2013 ACCF/AHA Guideline for the Management of Heart Failure: A Report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines

Mariell Jessup, MD, FACC, FAHA, Chair [*][1]

William T. Abraham, MD, FACC, FAHA[†][2]

Donald E. Casey, MD, MPH, MBA[‡][3]

Arthur M. Feldman, MD, PhD, FACC, FAHA[§][4]

Gary S. Francis, MD, FACC, FAHA[§][4]

Theodore G. Ganiats, MD[∥][5]

Marvin A. Konstam, MD, FACC[¶][6]

Donna M.

/pdf/2009-focused-update-incorporated-into-the-acc-aha-2005-3z9lhvyqwq.pdf

2009 Focused Update Incorporated Into the ACC/AHA 2005 Guidelines for the Diagnosis and Management of Heart Failure in Adults A Report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines: Developed in Collaboration With the International Society for Heart and Lung Transplantation

The medical profession should play a central role in evaluating the evidence related to drugs, …

https://www.minapharm.com/_handler/DownloadHandler.ashx?n=238.pdf&f=Attach&fileName=05020.pdf

2013 ACCF/AHA Guideline for the Management of Heart Failure: Executive Summary A Report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines

Ductal carcinoma in situ (DCIS) of the breast represents a heterogeneous group of neoplastic lesions in the breast ducts. The goal for management of DCIS is to prevent the development of invasive breast cancer. This manuscript focuses on the NCCN Guidelines Panel recommendations for the workup, primary treatment, risk reduction strategies, and surveillance specific to DCIS.

https://www.unitypoint.org/desmoines/filesimages/Cancer%20Education/Oncology%20Nursing%20Conference/2015/2014%20NCCN%20Clin%20Pract%20Guidelines%20Male%20Sex%20Dysf.pdf

Clinical practice guidelines in oncology

Background: Dyspnea is a common, distressing symptom of cardiopulmonary and neuromuscular diseases. Since the ATS published a consensus statement on dyspnea in 1999, there has been enormous growth in knowledge about the neurophysiology of dyspnea and increasing interest in dyspnea as a patient-reported outcome.Purpose: The purpose of this document is to update the 1999 ATS Consensus Statement on dyspnea.Methods: An interdisciplinary committee of experts representing ATS assemblies on Nursing, Clinical Problems, Sleep and Respiratory Neurobiology, Pulmonary Rehabilitation, and Behavioral Science determined the overall scope of this update through group consensus. Focused literature reviews in key topic areas were conducted by committee members with relevant expertise. The final content of this statement was agreed upon by all members.Results: Progress has been made in clarifying mechanisms underlying several qualitatively and mechanistically distinct breathing sensations. Brain imaging studies have consist...

/pdf/an-official-american-thoracic-society-statement-update-on-1ya95r8mpq.pdf

An Official American Thoracic Society Statement: Update on the Mechanisms, Assessment, and Management of Dyspnea

This systematic evidence review supports the American College of Physicians guideline on palliative care at the end of life. Strong to moderate evidence supports use of various treatments for cance...

Evidence for Improving Palliative Care at the End of Life: A Systematic Review

For the vast majority of Americans, the end of life includes a prolonged experience of chronic progressive disease, often associated with uncertainty, pain, suffering, and cost (Hogan et al. 2000; Lunney et al. 2003; National Consensus Project 2004; Teno 2005). For these reasons, coupled with an expansion of knowledge and research in managing and improving the dying experience, end-of-life care has been designated as a priority area for quality improvement, policy change and implementation, and cost effectiveness of work (Institute of Medicine 1997; Institute for the Future 2003; National Consensus Project 2004). In order to address end-of-life care, clinicians, administrators, researchers, and policy makers need to be able to evaluate the patient and caregiver experience.

However, end-of-life care is not a singular entity with a universal experience and well agreed upon course of care. Prognostication is poor and imprecise for most conditions, and patients and caregivers cope with illness for years, often with different trajectories of functional decline and needs (Lynn et al. 1997; Steinhauser et al. 2000, 2001; Patrick, Engelberg, and Curtis 2001; Lunney et al. 2003; Patrick et al. 2003; National Consensus Project 2004). The differing patterns of decline, as well as variable factors such as age, race, gender, culture, and preferences, suggest the need for diverse measures to assess the full spectrum of patients' and caregivers' end-of-life experience. From the health care system and policy perspective, it is also useful to consider the role of settings of care such as nursing homes, hospitals, home care, or hospice all play important roles and face different challenges in delivering care.

Substantial consensus derived from expert opinion and confirmed through nationally representative surveys of patients, families, and providers has established the principle domains to guide evaluation of the end-of-life experience (Hanson, Danis, and Garrett 1997; Lynn et al. 1997; Singer, Martin, and Kelner 1999; Steinhauser et al. 2000, 2001; Patrick, Engelberg, and Curtis 2001; Patrick et al. 2003; Wenrich et al. 2003; National Consensus Project 2004; Teno et al. 2004). Patients and families endorse important concerns including the extent to which care addresses pain and other physical and emotional symptoms, advance care planning, continuity of care, spiritual well-being, practical support for caregiving, and overall satisfaction. End-of-life care and palliative care have evolved over the last two decades to apply increasingly rigorous scientific methods to assess outcomes in these domains (National Consensus Project 2004; Teno 2005). Developing an adequate evidence base for improving end-of-life care requires reliable and valid measures of the patient and caregiver experience that also allow for comparability across the important care settings, populations, and clinical conditions.

As a part of systematic review of end-of-life care and outcomes, we identified measures that evaluate domains of the patient and caregiver experience and described their psychometric properties. Our objectives were to characterize measures that are available for evaluating end-of-life care and to characterize their use in the highest quality intervention studies that have been conducted in the field.

/pdf/a-systematic-review-of-measures-of-end-of-life-care-and-its-4093i935vz.pdf

A systematic review of measures of end-of-life care and its outcomes.

Depressive Disorders and Panic Attacks in Women with Bladder Pain Syndrome/Interstitial Cystitis

Off-label Use of Atypical Antipsychotics

/pdf/chronic-disease-self-management-for-diabetes-osteoarthritis-1wql1778qv.pdf

Lara Hilton

Papers

Evidence for Improving Palliative Care at the End of Life: A Systematic Review

A systematic review of measures of end-of-life care and its outcomes.

Depressive Disorders and Panic Attacks in Women with Bladder Pain Syndrome/Interstitial Cystitis

Off-label Use of Atypical Antipsychotics

Chronic Disease Self Management for Diabetes, Osteoarthritis, Post-Myocardial Infarction Care, and Hypertension